Evidence map›Paper›PMID 37239219›Full record

ArticleBrain sciences2023

Cerebral Amyloid Angiopathy-Related Inflammation (CAA-rI): Three Heterogeneous Case Reports and a Focused Literature Review.

Ivo Bozovic, Marta Jeremic, Aleksandra Pavlovic, Carna Jovanovic, Nikola Kresojevic, Nikola Vojvodic, Dejana Jovanovic, Dragoslav Sokic, Milija Mijajlovic

Open access · goldAbstract readCase Reports
In one paragraph

Article in Brain sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Ivo BozovicNeurology Clinic, University Clinical Center of Serbia, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-6623-0779
Marta JeremicNeurology Clinic, University Clinical Center of Serbia, University of Belgrade, 11000 Belgrade, Serbia.
Aleksandra PavlovicFaculty for Special Education and Rehabilitation, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-5987-9828
Carna JovanovicNeurology Clinic, University Clinical Center of Serbia, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0001-6023-7171
Nikola KresojevicNeurology Clinic, University Clinical Center of Serbia, University of Belgrade, 11000 Belgrade, Serbia.
Nikola VojvodicNeurology Clinic, University Clinical Center of Serbia, University of Belgrade, 11000 Belgrade, Serbia.
Dejana JovanovicNeurology Clinic, University Clinical Center of Serbia, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0003-4812-2763
Dragoslav SokicNeurology Clinic, University Clinical Center of Serbia, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0003-0226-9727
Milija MijajlovicNeurology Clinic, University Clinical Center of Serbia, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0003-0250-597X
University of Belgrade · RS

Funding

Wellcome Trust 200110
6 · The paper itself

Abstract

Cerebral amyloid angiopathy-related inflammation (CAA-rI) is a largely reversible, subacute encephalopathy, which is considered as a rare variant of cerebral amyloid angiopathy (CAA). Although the diagnosis of this inflammatory vasculopathy is generally clinico-pathologic, a probable or possible diagnosis can often be established based on current clinico-radiological diagnostic criteria. This is important since CAA-rI is considered as a treatable disorder, which most commonly occurs in the elderly population. Behavioral changes and cognitive deterioration are highlighted as the most common clinical signs of CAA-rI, followed by a heterogeneous spectrum of typical and atypical clinical presentations. However, despite the well-established clinical and radiological features incorporated in the current diagnostic criteria for this CAA variant, this rare disorder is still insufficiently recognized and treated. Here, we have shown three patients diagnosed with probable CAA-rI, with significant heterogeneity in the clinical and neuroradiological presentations, followed by different disease courses and outcomes after the introduction of immunosuppressive treatment. Moreover, we have also summarized up-to-date literature data about this rare, yet underdiagnosed, immune-mediated vasculopathy.

Indexed as

cerebral amyloid angiopathycerebral amyloid angiopathy-related inflammationdiagnosticsheterogeneous clinico-radiological presentationspatientsreviewtreatment

Identifiers

PMID37239219
PMCPMC10216068
OpenAlexW4367626710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.